Sector consensus Gan & Lee Pharmaceuticals.

Stocks

End-of-day quote Shanghai S.E. Other stock markets 10/06/2026			5-day change	1st Jan Change
56.14 ^CNY	+0.39%		+3.67%	-17.53%

05-15	Sandoz Group AG Confirms European Commission Approval for Biosimilars Bysumlog® (Insulin Lispro) and Dazparda® (Insulin Aspart), Strengthening Position in Diabetes	CI
05-07	Gan & Lee Pharmaceuticals Gets Nod to Market Dazparda in Europe	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
GAN & LEE PHARMACEUTICALS.			72.5	+29.14%	2
REGENERON PHARMACEUTICALS, INC.			833.31	+38.5%	28
UCB			289.47	+9.48%	19
SAMSUNG BIOLOGICS CO.,LTD.			2,096,122.22	+61.49%	23
CSL LIMITED			98.74	+36.6%	16
BIOGEN INC.			220.63	+13.58%	30
INCYTE CORPORATION			109.09	+3.51%	23
MODERNA, INC.			43.3	-5.85%	20
INNOVENT BIOLOGICS, INC.			101.64	+58.14%	26
SWEDISH ORPHAN BIOVITRUM AB			471.67	+8.43%	12
BRIDGEBIO PHARMA, INC.			102.71	+52.38%	23
AXSOME THERAPEUTICS, INC.			275.28	+11.75%	21
ALTEOGEN INC.			464,000	+47.3%	5
BIOMARIN PHARMACEUTICAL INC.			87.85	+56.39%	26
KRYSTAL BIOTECH, INC.			322.78	+3.32%	9
GRIFOLS, S.A.			14.58	+63.09%	12
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-	-	40.3	+30%	1
3SBIO INC.			31.4	+120.37%	10
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD	-	-	89.17	+60.96%	1
Average			134,911.93	+36.77%	16
Weighted average by Cap.			232,737.13	+30.99%	20